GE Healthcare
Imaging, monitoring, and healthcare IT solutions
Account Manager
Travel within the assigned region, including occasional overnight stays, is required.
About the job
- A minimum of 3 years of healthcare sales experience is required.
- Experience working with or selling critical care capital equipment, patient monitoring, ventilators, anaesthesia, infusion pumps, or similar technologies used in acute care settings is required or strongly valued.
- Understanding of critical care clinical workflows, hospital escalation pathways, and clinical decision-making processes within acute care units is required.
- Ability to engage effectively with intensive care unit nurses, emergency department clinicians, intensivists, biomedical engineers, and hospital procurement teams is required.
- Ability to multitask, prioritise, and manage time effectively is required.
- Interpersonal, influencing, listening, and networking skills are required to work independently and collaboratively.
- High-level presentation skills and the ability to communicate complex clinical and technical concepts effectively are required.
- A strong customer focus and professional presence are required.
- Proficiency in Microsoft Office Suite is required.
- Willingness to travel within the assigned region, including occasional overnight stays, and attend national meetings or tradeshows is required.
- A valid motor vehicle licence is required.
- Completion of all assigned quality and compliance training within defined deadlines is required.
- Compliance with the GE HealthCare Quality Manual, Quality Management System, relevant policies, laws, regulations, global privacy policies, and anti-competition policies is required.
- Achieve financial targets, including orders, sales, and profit key performance indicators, within the assigned territory.
- Manage customer relationship management funnel data proactively and punctually to facilitate accurate forecasting.
- Lead and coordinate proposals, prepare quotations, plan customer meetings, and demonstrate product solutions.
- Ensure accurate order configuration and entry.
- Analyse market dynamics and GE installed-base data to develop a strategic call cycle aligned with Patient Care Solutions priorities.
- Build, maintain, and grow relationships across key acute care accounts through consistent, high-quality interactions.
- Execute customer segmentation strategies and tailor offerings to clinical and market needs.
- Track and document customer interactions in SFDC with accurate, up-to-date contact information.
- Develop and maintain knowledge of GE HealthCare’s Patient Care Solutions portfolio, value propositions, and competitive landscape.
- Conduct product presentations, demonstrations, and clinical evaluations as needed.
- Provide Voice of Customer feedback to management, product leaders, service, and marketing teams.
- Collaborate with Product and Marketing teams on promotional events, product launches, and territory-specific initiatives.
- Identify, report, and support resolution of quality or compliance concerns.
- Drive continuous improvement across processes, work instructions, and procedures to standardise and simplify the Quality Management System.
- An Associate’s or Bachelor’s degree in a relevant business, technical, or clinical discipline is preferred.
- Healthcare sales exposure to critical care environments such as intensive care, emergency, or other high-acuity care areas is preferred.
About the company
GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.
Company Size
1-10
Company Stage
IPO
Headquarters
Chicago, Illinois
Founded
1892
Get referred to GE Healthcare
See people who can refer or advise you
Simplify's Take
What believers are saying
- Photonova Spectra won CE Mark on August 31, 2026, opening Europe sales.
- Q2 2026 orders rose 11.1%, with 1.15x book-to-bill and record backlog.
- Vivid cardiovascular ultrasound and ABUS breast screening launches broaden 2026 revenue opportunities.
What critics are saying
- Patient Care Solutions revenue fell 13.5% in Q2 2026; management is reviewing a sale.
- Jay Saccaro left in August 2026; William Grogan starts September 14, 2026.
- If PCS recovery slips into 2027, GE HealthCare becomes a slower-growth imaging vendor.
What makes GE Healthcare unique
- Photonova Spectra’s Deep Silicon CT differentiates GE HealthCare with photon-counting imaging.
- GE HealthCare spans imaging, pharma diagnostics, ultrasound, and monitoring across hospital workflows.
- The July 2026 backlog of $23.9 billion reflects sticky installed-base demand and services.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
401(k) Company Match
Tuition Reimbursement
Relocation Assistance
Company News
GE HealthCare has received CE mark approval for its Photonova Spectra photon-counting computed tomography system, enabling commercial sales in markets recognising CE marking. The clearance follows US Food and Drug Administration approval and Japanese regulatory clearance in March 2026. The system uses GE HealthCare's Deep Silicon detector technology to deliver ultra-high definition spectral and spatial imaging. It processes data volumes up to 50 times greater than conventional CT systems, utilising Nvidia's accelerated computing platform. Clinical collaborations are underway at UZ Brussel in Belgium and Rigshospitalet in Denmark to evaluate the system across cardiology, neurology, oncology and musculoskeletal imaging. The CE mark follows more than $5 billion in innovation investment by GE HealthCare.
Vertex Pharmaceuticals has emerged as a standout S&P 500 stock, according to StockStory's analysis. The company, which focuses on developing transformative medicines for serious diseases including cystic fibrosis and sickle cell disease, boasts a market capitalisation of $137.3 billion. Meanwhile, StockStory recommends avoiding two large-cap stocks. GE HealthCare, spun off from General Electric in 2023, faces concerns over stagnant organic revenue growth and declining operating margins. The medical equipment provider has a market cap of $32.4 billion. Wells Fargo also made the avoid list. The diversified financial services company, with a $262.2 billion market cap, has seen its net interest margin shrink by 33.6 basis points over two years, suggesting increased competition or declining loan profitability.
GE HealthCare has introduced three new cardiovascular ultrasound systems to its Vivid portfolio: Vivid Explorer 1, Vivid Advanced 1, and Vivid Focus 1. The systems were unveiled at the European Society of Cardiology Congress 2026 in Munich, Germany. Each system targets different clinical settings whilst sharing a common technology foundation with the ultra-premium Vivid Pioneer. Vivid Explorer is designed for high-volume echo labs, Vivid Advanced for mid-size hospitals and cardiology practices, and Vivid Focus for everyday cardiac imaging. All three systems use cSound imaging technology and include AI-enabled automation tools to streamline echo workflows. The systems have received CE Mark approval but are awaiting US FDA 510(k) clearance and are not yet available for sale in the United States.
GE HealthCare has launched Invenia ABUS Prime and ABUS StreamVue, expanding its breast imaging portfolio with solutions for supplemental screening in women with dense breasts. The Invenia ABUS Prime system has been installed at BeSound in Los Angeles, marking one of the first US installations. ABUS StreamVue is a browser-based reading solution enabling remote exam review across imaging networks. The system received FDA 510(k) clearance and CE Marking. Studies show 40% of women have dense breasts, carrying four to six times higher breast cancer risk. Research indicates mammography may miss one-third of cancers in dense breasts. Invenia ABUS Prime features AI-enabled tools including Scan Quality Assessment and can increase scan speed by up to 40%. The AI Assistant has demonstrated a 33% reduction in reading time.
GE HealthCare Technologies reported second-quarter results with orders rising 11% year-over-year and backlog reaching a record $23.9 billion. Revenue grew 3.5% organically to $5.3 billion, driven by Advanced Imaging Solutions and Pharmaceutical Diagnostics, which posted organic growth of 5% and 14.6% respectively. Patient Care Solutions remained weak, with revenue falling 13.5% due to component shortages and fulfilment problems. Management is reviewing strategic options for the segment, including a potential sale. The company maintained its full-year outlook of 3–4% organic sales growth, adjusted earnings per share of $4.80–$5.00, and approximately $1.6 billion in free cash flow. CFO Jay Saccaro is departing, with George Newcomb serving as interim CFO.